Hematology NewsGilteritinib shows safety, efficacy in relapsed/refractory AMLJune 24, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsAntibody from AML survivor may prove therapeuticJune 23, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCompany discontinues phase 3 trial of vadastuximab talirine in AMLJune 20, 2017Leukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology Times‘Admirable’ overall survival attainable in AML with enasidenibJune 16, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesDeep molecular responses achievable in AML pts treated with gilteritinibJune 12, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesMajority of AML patients do not receive recommended molecular genetic testingJune 11, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesDifferences emerge in new guidelines for managing FN in kidsJune 3, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsTransplantationAMLALLAggressive Lymphomas
Hematology TimesEC grants drug orphan designation for AMLMay 26, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesEMA recommends orphan designation for AML drugMay 25, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesDrug receives breakthrough designation for relapsed/refractory AMLMay 19, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesAntibody shows potential for treating AML, B-ALLMay 16, 2017Leukemia, Myelodysplasia, TransplantationAMLALL
Hematology TimesNovel inhibitor proves ‘potent’ in hematologic malignanciesMay 9, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLMyelodysplastic SyndromeHodgkin Lymphoma
Hematology TimesFormaldehyde probably doesn’t cause leukemia, team saysMay 3, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesCompany withdraws MAA for vosaroxin in AMLMay 3, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesDrug receives orphan designation for AMLMay 2, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
